Abstract:We read with interest the article by Ye and colleagues [1Ye B. Cheng M. Li W. et al.Predictive factors for lymph node metastasis in clinical stage Ia lung adenocarcinoma.Ann Thorac Surg. 2014; 98: 217-223Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar] about the predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma, in which they reported a 10.6% overall rate of lymph node metastasis.Theoretically, candidates for sublobar resection should be node negative; thus, it is important to improve the accuracy of clinical staging for cancer. According to the data of Ye and colleagues, factors such as ground-glass opacity status, serum carcinoembryonic antigen level, histologic subtype, and maximum standardized uptake value have potential for the prediction of lymph node metastasis. A prediction model based on some of these factors has been established to assess the possibility of lymph node metastasis in early-stage lung cancer [2Zhang Y. Sun Y. Xiang J. Hu H. Chen H. A prediction model for n2 disease in T1 non-small cell lung cancer.J Thorac Cardiovasc Surg. 2012; 144: 1360-1364Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar]. Some issues are worth noting here. First, the specific histology subtype (eg, acinar predominant, micropapillary predominant) was a reliable predictive factor both in the study of Ye and colleagues and in other research [3Zhang Y. Sun Y. Shen L. et al.Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable.Ann Surg Oncol. 2013; 20: 1949-1954Crossref PubMed Scopus (47) Google Scholar]. However, for the majority of lung cancer patients, the histology subtype is a postoperative pathologic diagnosis that is difficult to determine before operation because of the lack of a sufficient tumor specimen, so the histology subtype is of limited value for excluding node-positive patients preoperatively. Second, according to their univariate analyses, the node metastasis rates for patients with individual risk factors were less than 20%, suggesting that these predictive factors are insufficiently efficient for excluding node-positive patients.Two approaches have potential value in selecting candidates for sublobar resection. One is to identify high-risk patients for lymph node metastasis, followed by mediastinal staging evaluation. The other is the use of lymphatic tracers for sentinel lymph node mapping. A clinical study has demonstrated that an indocyanine green fluorescence imaging system is feasible for use in sentinel node biopsy and has a high overall accuracy rate of 80.7% [4Yamashita S. Tokuishi K. Anami K. et al.Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer.J Thorac Cardiovasc Surg. 2011; 141: 141-144Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar]. Optimization of the imaging system and lymphatic tracers for the sentinel lymph nodes would provide an accurate means of determining the optimal candidates for sublobar resection. We eagerly await the further development and refinement of this technology.Again, we congratulate Ye and colleagues on this brilliant study. We are confident that this study will optimize the selection of candidates for either invasive mediastinal staging or sublobar resection. We read with interest the article by Ye and colleagues [1Ye B. Cheng M. Li W. et al.Predictive factors for lymph node metastasis in clinical stage Ia lung adenocarcinoma.Ann Thorac Surg. 2014; 98: 217-223Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar] about the predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma, in which they reported a 10.6% overall rate of lymph node metastasis. Theoretically, candidates for sublobar resection should be node negative; thus, it is important to improve the accuracy of clinical staging for cancer. According to the data of Ye and colleagues, factors such as ground-glass opacity status, serum carcinoembryonic antigen level, histologic subtype, and maximum standardized uptake value have potential for the prediction of lymph node metastasis. A prediction model based on some of these factors has been established to assess the possibility of lymph node metastasis in early-stage lung cancer [2Zhang Y. Sun Y. Xiang J. Hu H. Chen H. A prediction model for n2 disease in T1 non-small cell lung cancer.J Thorac Cardiovasc Surg. 2012; 144: 1360-1364Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar]. Some issues are worth noting here. First, the specific histology subtype (eg, acinar predominant, micropapillary predominant) was a reliable predictive factor both in the study of Ye and colleagues and in other research [3Zhang Y. Sun Y. Shen L. et al.Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable.Ann Surg Oncol. 2013; 20: 1949-1954Crossref PubMed Scopus (47) Google Scholar]. However, for the majority of lung cancer patients, the histology subtype is a postoperative pathologic diagnosis that is difficult to determine before operation because of the lack of a sufficient tumor specimen, so the histology subtype is of limited value for excluding node-positive patients preoperatively. Second, according to their univariate analyses, the node metastasis rates for patients with individual risk factors were less than 20%, suggesting that these predictive factors are insufficiently efficient for excluding node-positive patients. Two approaches have potential value in selecting candidates for sublobar resection. One is to identify high-risk patients for lymph node metastasis, followed by mediastinal staging evaluation. The other is the use of lymphatic tracers for sentinel lymph node mapping. A clinical study has demonstrated that an indocyanine green fluorescence imaging system is feasible for use in sentinel node biopsy and has a high overall accuracy rate of 80.7% [4Yamashita S. Tokuishi K. Anami K. et al.Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer.J Thorac Cardiovasc Surg. 2011; 141: 141-144Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar]. Optimization of the imaging system and lymphatic tracers for the sentinel lymph nodes would provide an accurate means of determining the optimal candidates for sublobar resection. We eagerly await the further development and refinement of this technology. Again, we congratulate Ye and colleagues on this brilliant study. We are confident that this study will optimize the selection of candidates for either invasive mediastinal staging or sublobar resection. Predictive Factors for Lymph Node Metastasis in Clinical Stage IA Lung AdenocarcinomaThe Annals of Thoracic SurgeryVol. 98Issue 1PreviewSystematic lymph node dissection or sampling in all patients with clinical stage IA lung adenocarcinoma is currently controversial because the risk of lymph node metastasis is unclear. This study aimed to determine the predictive factors for lymph node metastasis in patients with clinical stage IA lung adenocarcinoma. Full-Text PDF

OA07.02 Omitting Intrapulmonary Lymph Node Retrieval May Affect the Oncological Outcome of Pn0 Lung Cancer Patients: A Propensity Score Match Analysis

Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.

Prognostic Impact of Lymphadenectomy on Outcomes of Sublobar Resection for Stage IA Non–small Cell Lung Cancer ≤2 Cm

Preoperative Lymph Node Assessment in Surgically Resected Pathologic T1 Lung Cancer Patients: Real World Clinical Practice in China.

The pattern of lymph node metastasis in peripheral pulmonary nodules patients and risk prediction models

The Extent of Mediastinal Lymph Node Dissection Correlates with Survival of Small Cell Lung Cancer Patients after Resection: a Propensity Score-Matched Cohort Study Analysis.

Effectiveness and Safety of Systematic and Selective Lymphadenectomies in Chinese Patients with Non-Small Cell Lung Cancer Who Received Sublobar Resection.

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

Optimal Lung Cancer Candidates for Sublobar Resection: Prediction of Pathologic Node-Negative Clinical Stage IA NSCLC.

Prognostic Significance of Preoperative Lymph Node Assessment for Patients with Stage Pn0 Esophageal Squamous Cell Carcinoma after Esophagectomy.

Surgical Results in Pathological N1 Nonsmall Cell Lung Cancer

Impact of the Number of Harvested Lymph Nodes on Long-term Survival in Node-Negative Non-small Cell Lung Cancer: Based on Clinical Stage but Not Pathological Stage

Mediastinal lymphadenectomy fulfilling NCCN criteria may improve the outcome of clinical N0-1 and pathological N2 non-small cell lung cancer.

The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer

Comparison of recurrence risk between patients with clinically node‐positive and ‐negative stage I non‐small cell lung cancer following surgery: A propensity score matching analysis

The Regularity and Clinical Significance of Intrapulmonary Lobar and Segmental Lymph Nodes Metastasis in Patients with Ct1n0m0 Stage Lung Adenocarcinoma

The prognostic significance of lymph nodes in patients with pT1c33N0M0 non-small cell lung cancer: a retrospective study

Detection of Occult Tumor Cells in Regional Lymph Nodes is Associated with Poor Survival in Pn0 Non-Small Cell Lung Cancer: a Meta-Analysis.

Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non‐small cell lung cancer: A propensity score matching analysis

Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer

Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0